SCHEMBL9603930

SCHEMBL9603930

Cc1ccc2oc(-c3ccc(-c4cccc5c4sc4ccccc45)cc3)nc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.57
RAB9A P51151 10/20 0.57
SMN1; SMN2 Q16637 10/20 0.57
NPC1 O15118 9/20 0.57
HPGD P15428 9/20 0.57
CASP3 P42574 4/20 0.57
SENP7 Q9BQF6 4/20 0.57
SENP6 Q9GZR1 4/20 0.57
SENP8 Q96LD8 3/20 0.57
POLB P06746 1/20 0.57
ALDH1A1 P00352 10/20 0.56
HSD17B10 Q99714 8/20 0.56
TP53 P04637 8/20 0.56
NFKB1 P19838 5/20 0.49
NFKB2 Q00653 5/20 0.49
RELA Q04206 5/20 0.49
MAPT P10636 4/20 0.49
L3MBTL1 Q9Y468 3/20 0.47
GLA P06280 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9603938 0.91 NPC1 (0.52) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL9603947 0.88 ALOX5 (0.46) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL9603934 0.88 ALOX5 (0.46) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL8512669 0.86 NPC1 (0.50) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL9603950 0.85 ALOX5 (0.48) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL9603887 0.85 NPC1 (0.49) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL9603963 0.84 NPC1 (0.51) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL9603889 0.81 NPC1 (0.48) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL23079980 0.81 SMN1; SMN2 (0.44) KDM4ERAB9ASMN1; SMN2NPC1HPGD
SCHEMBL17319278 0.81 ALOX5 (0.54) KDM4EHPGDALDH1A1HSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device XDH, AOX1, CYP4X1 KDM4E 2142/4885RAB9A 3002/4885SMN1; SMN2 3345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.